Natesto Gel, Metered
Product Images NDC 42667-5511

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Natesto (NDC 42667-5511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Acerus Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Nat07 0000 01)

An instructional line drawing showing a person applying nasal gel to one nostril by inserting the application device into the nose with one hand while slightly tilting the head back.*

FDA Label Image

Figure (Nat07 0000 02)

An instructional line drawing showing a person using Natesto nasal gel by inserting the metered nasal gel applicator tip into the nostril while holding the device with fingers, demonstrating the nasal administration route.*

FDA Label Image

Figure (Nat07 0000 03)

An illustration showing a cross-section of a Natesto nasal gel metered-dose container. The diagram labels the gel level indicator and piston inside the container.*

FDA Label Image

Figure (Nat07 0000 04)

Chemical structure diagram of testosterone, showing its molecular formula C19H28O2 and molecular weight 288.4.*

FDA Label Image

Figure 1 (Nat07 0000 05)

A line graph depicting mean total serum testosterone concentration (ng/dL) with standard deviation over 24 hours. The x-axis represents time in hours, while the y-axis shows testosterone concentration. Data show three distinct peaks around 0, 10, and 16 to 18 hours, with varying error bars indicating participant variability.*

FDA Label Image

Figure A (Nat07 0000 06)

Illustration of a Natesto nasal gel dispenser showing labeled parts including the hole, tip, pump, gel level indicator, piston, indicator window, actuator, and cap. The diagram details the components of the metered nasal gel delivery device for testosterone.*

FDA Label Image

Figure B (Nat07 0000 07)

An instructional line drawing showing a human hand holding a nasal spray device, demonstrating the proper finger positioning for use. The illustration focuses on the grip and handling technique for administering Natesto nasal gel.*

FDA Label Image

Figure C (Nat07 0000 08)

An instructional line drawing illustrating the correct application of Natesto nasal gel. It depicts a person raising a finger to their nasal passage, indicating nasal administration of the metered-dose gel spray.*

FDA Label Image

Figure D (Nat07 0000 09)

An instructional diagram showing a person using a nasal metered-dose gel spray. The person inserts the spray nozzle into one nostril and presses to release the gel, demonstrating correct administration technique for nasal gel products.*

FDA Label Image

Figure E (Nat07 0000 10)

Instructional line drawing showing a person applying nasal gel to their nostril. The image likely relates to the proper use of Natesto nasal gel, a testosterone metered-dose nasal gel, illustrating the method of nasal administration.*

FDA Label Image

Figure F (Nat07 0000 11)

Illustration showing a person self-administering Natesto nasal gel by inserting the applicator tip into one nostril and pressing to release the metered dose. The diagram highlights the correct hand positioning and insertion angle for nasal gel administration.*

FDA Label Image

Figure G (Nat07 0000 12)

An instructional line drawing showing a person inserting their finger into a nostril, presumably demonstrating the administration technique for a nasal gel product.*

FDA Label Image

Figure H (Nat07 0000 13)

An instructional diagram illustrating a metered nasal gel dispenser. The image highlights the gel level indicator and piston components of the device, demonstrating how the gel amount inside the container is visible and controlled for dosing.*

FDA Label Image

Nat07 0000 14

Packaging label for Natesto nasal gel 5.5 mg/.122 g, a metered nasal gel containing testosterone. The label indicates each actuation delivers 0.122 g of gel and the multi-dose pump dispenses 60 actuations. The product is for intranasal use only and is marketed by Acerus Pharmaceuticals Corporation, with manufacturing by Haupt Pharma Amareg GmbH, Germany. The label includes warnings, active and inactive ingredients, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.